Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Jul 10;116(2):134-42.
doi: 10.1161/CIRCULATIONAHA.106.659086. Epub 2007 Jun 25.

SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome

Affiliations
Case Reports

SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome

Argelia Medeiros-Domingo et al. Circulation. .

Abstract

Background: Congenital long-QT syndrome (LQTS) is potentially lethal secondary to malignant ventricular arrhythmias and is caused predominantly by mutations in genes that encode cardiac ion channels. Nearly 25% of patients remain without a genetic diagnosis, and genes that encode cardiac channel regulatory proteins represent attractive candidates. Voltage-gated sodium channels have a pore-forming alpha-subunit associated with 1 or more auxiliary beta-subunits. Four different beta-subunits have been described. All are detectable in cardiac tissue, but none have yet been linked to any heritable arrhythmia syndrome.

Methods and results: We present a case of a 21-month-old Mexican-mestizo female with intermittent 2:1 atrioventricular block and a corrected QT interval of 712 ms. Comprehensive open reading frame/splice mutational analysis of the 9 established LQTS-susceptibility genes proved negative, and complete mutational analysis of the 4 Na(vbeta)-subunits revealed a L179F (C535T) missense mutation in SCN4B that cosegregated properly throughout a 3-generation pedigree and was absent in 800 reference alleles. After this discovery, SCN4B was analyzed in 262 genotype-negative LQTS patients (96% white), but no further mutations were found. L179F was engineered by site-directed mutagenesis and heterologously expressed in HEK293 cells that contained the stably expressed SCN5A-encoded sodium channel alpha-subunit (hNa(V)1.5). Compared with the wild-type, L179F-beta4 caused an 8-fold (compared with SCN5A alone) and 3-fold (compared with SCN5A + WT-beta4) increase in late sodium current consistent with the molecular/electrophysiological phenotype previously shown for LQTS-associated mutations.

Conclusions: We provide the seminal report of SCN4B-encoded Na(vbeta)4 as a novel LQT3-susceptibility gene.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical characterization and molecular discovery of L179F-SCN4B. A, Electrocardiographic evaluation of 21-month-old index case shows QTc=712 ms and 2:1 AV block. B, Holter evaluation of index case shows T wave alternans during 1:1 conduction. C, Pedigree; affected status was assigned as outlined previously: QTc>440 ms in males and >460 ms in females. QTc values are shown below each individual. Ages at clinical evaluation are shown above each individual. *Age at death. D, DNA sequencing chromatograms demonstrate a leucine (L) to phenylalanine (F) substitution at residue 179. Bottom, Aberrant denaturing high-performance liquid chromatography profile. Top, Wild-type.
Figure 2
Figure 2
Location of L179F in the β4 subunit. A, Linear topology of the β4 subunit. Numbering of the amino acid sequence is relative to the full-length gene product. B, L179F conservation across species.
Figure 3
Figure 3
Functional characterization of L179F in HEK293 cells stably transfected with SCN5A-encoded Nav1.5 α-subunit. A, Representative traces of sodium channel current recorded with the whole-cell configuration of the patch-clamp technique for a clamp step from −140 mV to various potentials. Current amplitude and time course are shown on each panel for the sodium channel alone, sodium channel plus WT-β4, and sodium channel plus β4 mutant. No significant differences in amplitude or current/time course were noted (Summary data in Table 2). B, Steady-state voltage dependence of activation (right plot) and inactivation (left plot) with and without WT-β4 or L179F-β4. Data are means of measurements, and the lines are Boltzmann fits with n numbers and parameters of the fit found in Table 2. C, Detail of the “window” current where the activation curves overlap the inactivation curves. L179F increases window current. INa indicates robust sodium current; GNa, sodium conductance (calculated from peak sodium current [INa] divided by the driving force [V–Na reversal potential]).
Figure 4
Figure 4
Effect of coexpression of L179F-β4 mutant on late sodium current. A, Representive sodium current traces in response to a step to −60 mV for 700 ms from a holding potential of −140 mV (protocol inset) are shown. Leak-subtracted currents were normalized to peak current and are shown on a scale such that peak current is off-scale to emphasize the small late component. B, Summary data showed that L179F-β4 mutant increased late sodium current during the window of terminal repolarization as much as the α subunit sodium channel mutation (ΔKPQ) that causes LQT3.
Figure 5
Figure 5
Coimmunoprecipitation of SCN5A and β4 subunit. The lysates were obtained from untransfected HEK cells (column 1) and from cells cotransfected with HA-SCN5A and Myc-β4 (column 2). Columns 3 to 6 are immunoprecipitation protein complexes derived from cotransfection of HA-SCN5A and Myc-β4-WT; HA-SCN5A and Myc-β4-L179F; HA-SCN5A and untagged β4-WT; and HA-SCN5A and untagged β4-L179F, respectively. The 38-kDa line recognizes the β4 subunit, and the bands above 38 kDa show nonspecific binding. Column 1 shows no recognition in control; column 2 shows recognition of the expressed Myc label. In columns 3 and 4, the β4 subunit was recognized in the SCN5A precipitate for both WT and L179F (red arrows). In columns 5 and 6, the β4 subunit was not recognized because the complex of unlabeled SCN5A and Myc-β4 were not precipitated.

References

    1. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803. - PubMed
    1. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–11. - PubMed
    1. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005;2:507–517. - PubMed
    1. Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, Bottelli G, Cerrone M, Leonardi S. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice [see comment] JAMA. 2005;294:2975–2980. - PubMed
    1. Meadows LS, Isom LL. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res. 2005;67:448–458. - PubMed

Publication types